Literature DB >> 35839449

Clonal hematopoiesis is not significantly associated with COVID-19 disease severity.

Yifan Zhou1,2,3, Ruba Shalhoub4, Stephanie N Rogers1, Shiqin Yu2, Muxin Gu1,3, Margarete A Fabre1,3,5, Pedro M Quiros1,3, Tae-Hoon Shin2,6, Arch Diangson7, Wenhan Deng7, Shubha Anand7, Wenhua Lu8, Matthew Cullen8, Anna L Godfrey9, Jacobus Preller10, Jerome Hadjadj11, Emmanuelle Jouanguy12,13, Aurélie Cobat12,13, Laurent Abel12,13,14, Frederic Rieux-Laucat15, Benjamin Terrier11, Alain Fischer16,17, Lara Novik18, Ingelise J Gordon18, Larisa Strom18, Martin R Gaudinski18, Andrea Lisco19, Irini Sereti19, Thomas J Gniadek20, Andrea Biondi21, Paolo Bonfanti22, Luisa Imberti23, Clifton L Dalgard24, Yu Zhang25,26, Kerry Dobbs26, Helen C Su25,26,27, Luigi D Notarangelo25,26, Colin O Wu4, Peter J M Openshaw28, Malcolm G Semple29, Ziad Mallat30,31,32, Kenneth Baillie33,34,35, Cynthia E Dunbar2, George S Vassiliou1,3,5.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35839449      PMCID: PMC9293387          DOI: 10.1182/blood.2022015721

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   25.476


× No keyword cloud information.
  1 in total

1.  Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years.

Authors:  Marta Del Pozo-Valero; Marta Corton; Rosario López-Rodríguez; Ignacio Mahillo-Fernández; Javier Ruiz-Hornillos; Pablo Minguez; Cristina Villaverde; María Elena Pérez-Tomás; María Barreda-Sánchez; Esther Mancebo; Estela Paz-Artal; Encarna Guillén-Navarro; Berta Almoguera; Carmen Ayuso
Journal:  Geroscience       Date:  2022-10-03       Impact factor: 7.581

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.